Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

8,533 total articles

DHT: Market Has Largely Priced The Downside - A Tactical Long Opportunity

DHT: Market Has Largely Priced The Downside - A Tactical Long Opportunity

DHT Holdings trades at a bargain-like multiple with a near-9% yield, recent asset sales that added ~$95M of net cash and early delivery of newbuildings that should lift earning power. The market has already baked in much of the geopolitical and charter-rate risk; we see a mid-term long trade with defined entry, stop and target that offers attractiv…

Why Palantir's AI Moat Is Widening and How to Trade It

Why Palantir's AI Moat Is Widening and How to Trade It

Palantir's enterprise AI platform is moving from bespoke deployments to repeatable product offerings. Strong growth, high margins, improving technicals, and a recent pullback make a disciplined long trade attractive over the next 45 trading days, provided Palantir sustains commercial expansion and earnings power.

Why a Palantir-Nvidia Tie-Up Could Be the Next Big Catalyst for NVDA

Why a Palantir-Nvidia Tie-Up Could Be the Next Big Catalyst for NVDA

Nvidia's leadership in AI compute makes it the natural partner for software platforms like Palantir. If a commercial partnership or strategic deal surfaces, NVDA should see meaningful re-rating. This trade idea lays out a mid-term swing entry at $197.81, a stop at $185.00 and a primary target at $236.54 (52-week high), with clear catalysts and a ri…

Nvidia: Buy the Moat, Manage the Volatility

Nvidia: Buy the Moat, Manage the Volatility

Nvidia remains the dominant supplier of AI compute and networking hardware with industry-leading margins, massive free cash flow and a fortress balance sheet. At $195, the stock offers a tactical long opportunity for disciplined traders: entry $195.00, stop $170.00, target $260.00 over a long-term 180 trading day horizon. The upside is driven by co…

Buy the Post-CRL Setup in Achieve Life Sciences — Approval Still Achievable, Risk-Reward Looks Compelling

Buy the Post-CRL Setup in Achieve Life Sciences — Approval Still Achievable, Risk-Reward Looks Compelling

Achieve Life Sciences (ACHV) carries headline risk from a recent Complete Response Letter, but fundamentals and setup support a constructive position trade. The company still commands a market cap near $660M, has a meaningful NDA timeline and $45M capital raise behind the program. We outline an explicit entry, stop and $12 target on a 180-trading-d…

Gorman-Rupp (GRC): A No-Name Long Shot Worth a Small, Structured Bet

Gorman-Rupp (GRC): A No-Name Long Shot Worth a Small, Structured Bet

Gorman-Rupp sells pumps — but recent demand from data-center cooling and infrastructure has turned this sleepy small-cap into a volatile, opportunity-rich name. Valuation looks full at ~38x earnings, yet cash flow, a healthy balance sheet and a tight float mean a disciplined, mid-term long can pay off. Below: why I’m watching GRC, the concrete trad…

Bioventus: Better Business, Fair Price - A Tactical Upgrade

Bioventus: Better Business, Fair Price - A Tactical Upgrade

Bioventus (BVS) has stronger cash generation, a cleaner credit profile and an end-market tailwind behind osteoarthritis and fracture-healing therapies. At roughly $11.69 today and a market cap near $1.0B, the stock looks fairly valued vs. fundamentals but offers an asymmetric swing trade: buy now for a re-rating toward a mid-30s P/E as execution an…

CoreWeave: Time to Buy the Dip — Upgrading to Buy

CoreWeave: Time to Buy the Dip — Upgrading to Buy

CoreWeave has pulled back sharply despite accelerating AI infrastructure demand and a scalable, capex-efficient model. We upgrade to Buy and lay out a core trade with clear entry, stop and targets across horizons. The setup favors disciplined size and patience given short-term volatility.

Nu Holdings: Big Growth, Real Execution Risk - A Controlled Long Trade

Nu Holdings: Big Growth, Real Execution Risk - A Controlled Long Trade

Nu Holdings is one of the fastest-growing digital banks in Latin America with 135 million customers and Q1 2026 revenue of $5.32 billion. The growth runway is large, but currency, credit and execution risks are real. This trade idea lays out a disciplined long entry with a $13.80 pivot, a $11.50 stop and a $19.00 target over a 180-trading-day horiz…

Shift4: From Payments Processor to a Protected Commerce Niche — A Long Trade with Leverage to Global Blue

Shift4: From Payments Processor to a Protected Commerce Niche — A Long Trade with Leverage to Global Blue

Shift4 (FOUR) has evolved beyond card rails into a structurally defensive niche after the Global Blue acquisition. Strong free cash flow, accelerating payment volumes, and insider buying create a high-conviction long. Risks include heavy leverage, integration execution and macro pressure on travel spend. I recommend a long entry at $51.47 with $46.…

IREN: Play the Rumor, Hedge the Risk

IREN: Play the Rumor, Hedge the Risk

IREN has reappeared in takeover chatter. The market is pricing in a deal that is not yet signed — creating a defined, asymmetric trade: buy weakness now with a strict stop and a mid-term target reflecting a likely takeover premium. This idea sizes for conviction but includes a clear exit if the paperwork never arrives.

Universal Music: Why the Bull Case Has Strengthened Since 2024

Universal Music: Why the Bull Case Has Strengthened Since 2024

Universal Music's advantages in catalog breadth, artist relationships and emerging AI licensing create a clearer path to margin expansion and revenue upside than two years ago. This note lays out an actionable long trade with entry, stop and targets and explains the key catalysts and risks that should move the stock.

Crescent Energy: Cash Flow Is Buying the Stock for You

Crescent Energy: Cash Flow Is Buying the Stock for You

Crescent Energy is trading at roughly 8x price-to-free-cash-flow with an implied FCF yield north of 12% and a >5% cash distribution. With enterprise-value multiples under 5x EBITDA and projected merger synergies of $90-100M, this name looks attractively priced versus the risk of a cyclical earnings drag. I present an actionable long trade with entr…

Coinbase: Institutional On-Ramp, Discounted After the Dip

Coinbase: Institutional On-Ramp, Discounted After the Dip

Coinbase is the dominant regulated gateway for institutions entering crypto markets. Recent weakness offers an opportunity to buy a prime-brokerage style business exposed to rising institutional flows, stablecoin partnerships, and onchain product revenue. This trade targets a recovery toward $220 over 180 trading days with a strict stop at $145 to …